Hexarelin For Sale — Research Grade
PX1 Research supplies high-purity Hexarelin for sale exclusively to qualified academic, biotechnology, and institutional researchers. Synthesized under stringent manufacturing controls and verified via independent analytical testing, our Hexarelin lyophilized peptide ensures high batch-to-batch consistency for preclinical research.
Quick answer
PX1 Research supplies high-purity Hexarelin for sale exclusively to qualified academic, biotechnology, and institutional researchers. Synthesized under stringent manufacturing controls and verified via independent analytical testing, our Hexarelin lyophilized peptide ensures high batch-to-batch consistency for preclinical research.
Key takeaways
- When purchasing compounds for laboratory experimentation, data reproducibility relies heavily on reagent purity, sequence integrity, and the absence of toxic bio-burden.
- [Hexarelin](/research-peptides/hexarelin) (chemically known as L-histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide) is a synthetic hexapeptide belonging to the growth hormone secretagogue (GHS) class.
- In vitro data indicate that [Hexarelin](/research-peptides/hexarelin) acts as a potent full agonist at the growth hormone secretagogue receptor type 1a (GHSR-1a), a G-protein coupled receptor (GPCR) predominantly expressed in the anterior pituitary gland and hypothalamus, as well as peripheral tissues such as the myocardium.
- In preclinical endocrine research, [Hexarelin](/research-peptides/hexarelin) serves as a established standard for studying somatotroph responsiveness and pituitary feedback mechanisms.
High-Purity Hexarelin Sourcing for Preclinical Research
When purchasing compounds for laboratory experimentation, data reproducibility relies heavily on reagent purity, sequence integrity, and the absence of toxic bio-burden. PX1 Research offers high-purity Hexarelin specifically formulated for in vitro assays, cell culture models, and preclinical animal research. Sourced through standardized synthesis protocols, each lot undergoes rigorous testing to guarantee optimal biochemical baseline performance.
Investigators conducting experiments on the growth hormone (GH) axis, receptor kinetics, or tissue metabolism require reliable reference standards. Inconsistent purity levels or unidentified synthetic sequence truncation can confound experimental results, distorting binding affinity metrics or signal transduction assays. PX1 Research addresses these critical variables by applying stringent analytical verification protocols to every batch of research peptides supplied to academic and industrial research facilities.
Chemical Profile and Structural Properties of Hexarelin
Hexarelin (chemically known as L-histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide) is a synthetic hexapeptide belonging to the growth hormone secretagogue (GHS) class. Featuring the molecular formula C47H58N12O6 and a molecular weight of approximately 887.04 g/mol, Hexarelin incorporates non-natural D-amino acid substitutions designed to enhance its chemical stability and metabolic resistance against native proteolytic enzymes.
The specific sequence—His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2—was engineered to optimize target binding with the growth hormone secretagogue receptor 1a (GHSR-1a). The inclusion of 2-methyl-D-tryptophan significantly alters its steric configuration compared to endogenous ligands like ghrelin, influencing ligand-receptor binding kinetics and internal signaling downstream. Research laboratories studying peptide stability utilize Hexarelin as a model compound for investigating resistance to serine proteases and peptidases.
Mechanism of Action: Target Binding and Signal Transduction
In vitro data indicate that Hexarelin acts as a potent full agonist at the growth hormone secretagogue receptor type 1a (GHSR-1a), a G-protein coupled receptor (GPCR) predominantly expressed in the anterior pituitary gland and hypothalamus, as well as peripheral tissues such as the myocardium. Upon binding to GHSR-1a, Hexarelin triggers a conformational change that activates the phospholipase C (PLC) pathway, leading to the generation of inositol trisphosphate (IP3) and diacylglycerol (DAG).
This cascade causes the rapid release of intracellular calcium ions (Ca2+) from the endoplasmic reticulum and activates protein kinase C (PKC). Preclinical rodent models demonstrate that this intracellular signal transduction pathway leads to exocytosis of somatotroph storage vesicles, producing a concentration-dependent surge in growth hormone release. Notably, Hexarelin exhibits unique binding profile dynamics, including secondary interaction with CD36 (a scavenger receptor class B member), distinguishing its peripheral signaling properties from other classical growth hormone secretagogues.
Investigational Horizons in Endocrine and Metabolic Models
In preclinical endocrine research, Hexarelin serves as a established standard for studying somatotroph responsiveness and pituitary feedback mechanisms. Animal models evaluated under dynamic physiological conditions reveal that Hexarelin administration produces a pronounced GH spike that surpasses the baseline response elicited by endogenous growth hormone-releasing hormone (GHRH). Researchers routinely utilize Hexarelin to investigate the synergistic pathways activated when combining ghrelin receptor agonists with GHRH analogs such as CJC-1295 No DAC.
Beyond pituitary hormone secretion, research models have established Hexarelin as a valuable tool for investigating substrate metabolism, lean tissue preservation, and nitrogen retention under catabolic stress. In vitro cell cultures exposed to Hexarelin demonstrate alterations in lipid storage pathways and glucose transport dynamics, providing insights into ghrelin-mediated metabolic homeostasis.
Cardioprotective and Peripheral Tissue Investigations
A distinct feature of Hexarelin highlighted across preclinical literature is its GH-independent peripheral activity, mediated largely through its interaction with the CD36 scavenger receptor and cardiac GHSR-1a. Rodent models of ischemia-reperfusion injury and isolated heart preparations demonstrate that Hexarelin exposure correlates with a reduction in myocardial cell apoptosis, decreased infarct size, and improved post-ischemic hemodynamic recovery.
These cardioprotective research findings suggest that Hexarelin's mechanism involves modulation of mitochondrial membrane potential, suppression of reactive oxygen species (ROS) generation, and upregulation of anti-apoptotic proteins like Bcl-2. Investigators studying cardiovascular pathology utilize research-grade Hexarelin to map the precise molecular pathways involved in microvascular tone, endothelial function, and cardiac remodeling following mechanical or chemical ischemia.
Comparative Analysis: Hexarelin vs. GHRP-2, GHRP-6, and Ipamorelin
To select the appropriate synthetic candidate for target receptor assays, researchers frequently compare Hexarelin against other prominent compounds in the secretagogue family. While sharing structural and functional overlap with GHRP-2 and GHRP-6, Hexarelin demonstrates higher potency regarding peak amplitude of growth hormone release in acute animal models. However, Hexarelin also displays distinct receptor desensitization kinetics upon repetitive exposure, a phenomenon frequently studied in receptor downregulation assays.
Conversely, when compared to selective secretagogues like Ipamorelin, Hexarelin exerts a broader endocrine footprint. While Ipamorelin displays minimal effect on cortisol and prolactin pathways, preclinical data indicate that Hexarelin induces transient, moderate elevations in plasma cortisol and prolactin in animal models at high dosages. Understanding these distinct pharmacodynamic properties allows investigators to select the precise peptide candidate for their specific experimental parameters.
PX1 Research Quality Verification: HPLC and Mass Spectrometry Protocols
The utility of synthetic peptides in analytical research depends entirely on chemical identity and chemical purity. PX1 Research enforces rigorous quality control metrics for every lot of Hexarelin synthesized. Analysis is conducted in an ISO 17025 accredited laboratory utilizing High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to verify both sequence fidelity and exact molecular weight.
Our analytical benchmark requires that every batch of Hexarelin meet or exceed a target chemical purity threshold of >98% by HPLC area under the curve. Mass spectrometry analysis confirms the correct molecular mass (887.04 Da) and verifies the absence of truncated sequences, deletion peptides, or residual protecting groups. To review transparent verification details, researchers can access lot-specific Certificates of Analysis (COAs) directly through our portal, ensuring complete transparency prior to experimental deployment.
Endotoxin Control and Bio-burden Standards
In cell culture work, primary tissue assays, and sensitive preclinical models, the presence of bacterial endotoxins (lipopolysaccharides) can induce unwanted inflammatory signaling, masking experimental results or causing non-specific cytotoxicity. PX1 Research integrates specialized purification processes to minimize bio-burden in all manufactured lots.
Every batch of research-grade Hexarelin undergoes quantitative Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below institutional research tolerances (<0.01 EU/μg). By ensuring non-interfering physiological baselines, PX1 Research empowers researchers to generate clean, repeatable data across cellular, histological, and animal research platforms. Detailed protocol guidelines are available via our peptide purity standards technical documentation.
Reconstitution and Laboratory Handling Protocols
Hexarelin is supplied as a lyophilized (freeze-dried) sterile powder to ensure maximal structural stability during transport and storage. To reconstitute the compound for laboratory procedures, investigators should follow standard aseptic techniques inside a laminar flow hood. Bacteriostatic Water or sterile 0.9% sodium chloride solution should be introduced down the glass vial wall to prevent shearing forces from degrading the peptide matrix.
Gentle swirling is recommended to achieve complete dissolution; vigorous agitation or vortexing must be avoided as it can cause peptide denaturation. Once reconstituted, liquid aliquots should be used immediately or stored at -20°C to -80°C to maintain stability over extended experimental timelines. Repeated freeze-thaw cycles must be avoided to prevent mechanical disruption of the peptide structure.
Ordering Hexarelin: Immediate Logistics and Institutional Accounts
PX1 Research maintains a fully stocked inventory of Hexarelin for sale, ensuring uninterrupted workflow for academic institutions, biotechnology companies, and private research laboratories. Orders placed Monday through Friday before cut-off times are dispatched same-day from our primary USA fulfillment centers located in California and Arizona.
All shipments are packaged using protective temperature-mitigating materials to protect peptide integrity during transit. Facilities requiring bulk quantities, custom vial sizing, or recurring batch reservations can establish institutional accounts via our wholesale accounts department, securing dedicated lot allocation and customized quality assurance documentation.
Frequently Asked Questions
What purity level is guaranteed when purchasing Hexarelin for sale from PX1 Research?
Every lot of Hexarelin supplied by PX1 Research is certified to meet or exceed >98% purity as determined by High-Performance Liquid Chromatography (HPLC) and confirmed by Mass Spectrometry (MS).
Are Certificates of Analysis (COAs) provided with each Hexarelin shipment?
Yes. Every individual lot of Hexarelin includes a lot-specific COA verified by an independent ISO 17025 accredited laboratory, detailing HPLC chromatograms, mass spec analysis, and endotoxin test results.
How should lyophilized Hexarelin be stored upon delivery?
Unreconstituted lyophilized Hexarelin powder should be stored in a dry environment at or below -20°C for long-term stability. Short-term storage at 2°C to 8°C is acceptable during immediate active experimental phases.
What solvent is recommended for reconstituting Hexarelin for laboratory assays?
For most in vitro and preclinical research applications, reconstituting with sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile laboratory-grade saline is recommended depending on the specific sensitivity of the cell line or model system.
What is the primary receptor target of Hexarelin in preclinical models?
Hexarelin acts primarily as a full agonist at the growth hormone secretagogue receptor 1a (GHSR-1a) and displays secondary binding activity at the scavenger receptor CD36.
Does PX1 Research conduct endotoxin testing on Hexarelin?
Yes. All batches undergo Limulus Amebocyte Lysate (LAL) testing to confirm that endotoxin levels are maintained well below standard thresholds (<0.01 EU/μg) for preclinical research safety.
How does Hexarelin differ functionally from Ipamorelin in research setups?
While both activate the GHSR-1a receptor to stimulate GH release, Hexarelin exhibits greater peak potency in acute models and secondary activity at CD36 receptors, whereas Ipamorelin displays higher selectivity with minimal impact on cortisol or prolactin.
Can laboratories set up recurring bulk orders for Hexarelin?
Yes, research institutions and industrial clients can register for institutional accounts via the PX1 wholesale portal to secure dedicated lot numbers, customized batch sizes, and volume pricing.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.